Apremilast Devatis 10 mg, 20 mg, 30 mg, Filmtabletten

7680700160018 CH-70016 Filmtabletten

Associated product:

Apremilast Devatis emballage départ cpr pell 4x10,4x20,19x30mg, , Apremilast Devatis emballage départ cpr pell 4x10,4x20

No image available

Article details

Package size
4 + 4 + 19
Selling units
4
Measure
Tablette(n)
Galenic form
Filmtabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
07/09/2026
Summary of Product Characteristics
Français
07/09/2026
Summary of Product Characteristics
Italien
07/09/2026
Patient information leaflet
Allemand
06/08/2025
Patient information leaflet
Français
06/08/2025
Patient information leaflet
Italien
06/08/2025

Detailed composition

Substance Quantity Type Category
apremilastum
30.0 MG Substance Wirkstoff (Principe actif)
apremilastum
10.0 MG Substance Wirkstoff (Principe actif)
apremilastum
20.0 MG Substance Wirkstoff (Principe actif)
cellulosum microcristallinum
- Substance HNIDK
cellulosum microcristallinum
- Substance HNIDK
cellulosum microcristallinum
- Substance HNIDK
lactosum monohydricum
180.0 MG Substance HBESI
lactosum monohydricum
60.0 MG Substance HBESI
lactosum monohydricum
120.0 MG Substance HBESI
carmellosum natricum conexum
- Substance HNIDK
carmellosum natricum conexum
- Substance HNIDK
carmellosum natricum conexum
- Substance HNIDK
natrium
0.81 MG Substance HBESI
natrium
0.27 MG Substance HBESI
natrium
0.54 MG Substance HBESI
magnesii stearas
- Substance HNIDK
magnesii stearas
- Substance HNIDK
magnesii stearas
- Substance HNIDK
hypromellosum
- Substance HNIDK
hypromellosum
- Substance HNIDK
hypromellosum
- Substance HNIDK
titanii dioxidum
- Substance HNIDK
titanii dioxidum
- Substance HNIDK
titanii dioxidum
- Substance HNIDK
macrogolum 400
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
macrogolum 400
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
macrogolum 400
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
E 172 (flavum)
- Substance FTODK
E 172 (flavum)
- Substance FTODK
E 172 (flavum)
- Substance FTODK
E 172 (rubrum)
- Substance FTODK
E 172 (rubrum)
- Substance FTODK
E 172 (rubrum)
- Substance FTODK
talcum
- Substance HNIDK
E 172 (nigrum)
- Substance FTODK

Reimbursement information

Public price
CHF 161.60
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/09/2025

Authorization holder

Devatis AG

6330 Cham

Authorization information

Swissmedic authorization number
70016
Drug name
Apremilast Devatis, Filmtabletten
Galenic form
FILM
ATC Code
L04AA32
Authorization status
Z
Dispensing category
B
First authorization
22/07/2025
Authorization expiration date
21/07/2030
IT Number
07.15.0.
Domain
Human medicine
Field of application
Aktive Psoriasis-Arthritis und mittelschwere bis schwere Plaque-Psoriasis

Package details

Description (FR)
APREMILAST Devatis cpr pellic 10 mg 4+4+19 pce
Description (DE)
APREMILAST Devatis Filmtabl 10 mg 4+4+19 Stk
Market launch
14/08/2025
Market withdrawal
14/08/2025
Narcotic (BTM)
No

Original drug

Otezla, Filmtabletten
GTIN: 7680653460036
CHF 334.85
View original

Other package sizes (1)

APREMILAST Devatis cpr pellic 30 mg 56 pce
56 TABL
GTIN: 7680700160025
View
Buy us a coffee Explore the data